Medicine and Dentistry
Surgery
100%
Neoplasm
80%
Soft Tissue Sarcoma
77%
Recurrent Disease
73%
Bone Metastasis
69%
Metastatic Carcinoma
63%
Radiation Therapy
58%
Diseases
54%
Osteosarcoma
39%
Malignant Neoplasm
37%
Connective Tissue Cancer
32%
Chondrosarcoma
29%
Synovial Sarcoma
28%
Overall Survival
26%
Ewing Sarcoma
26%
Pelvis
24%
Limb
23%
Pathologic Fracture
22%
Clear Cell Renal Cell Carcinoma
18%
Intramedullary Nailing
17%
Hazard Ratio
17%
Preoperative Radiotherapy
17%
Surgical Margin
16%
Magnetic Resonance Imaging
15%
Primary Tumor
14%
Bone Cancer
14%
Prognostic Factor
13%
Neck
13%
Local Recurrence Free Survival
13%
Survival Rate
13%
Nail
13%
Doxorubicin
13%
Disease Specific Survival
12%
Progression Free Survival
12%
Wound Complication
12%
Musculoskeletal Tumor
12%
Femur Fracture
11%
Kaplan Meier Method
11%
Ifosfamide
11%
Surgeon
11%
Tumor Recurrence
11%
Cumulative Incidence
10%
Bone Grafting
10%
Limb Salvage
10%
Allograft
10%
Fibula Graft
10%
Bone Graft
10%
Prosthetics
10%
Patient-Reported Outcome
10%
Localized Disease
10%
Keyphrases
Soft Tissue Sarcoma
36%
Synovial Sarcoma
32%
Chemotherapy
23%
Tumor
21%
Local Recurrence
20%
Osteosarcoma
19%
Combined Modality Therapy
18%
Local Control
17%
Overall Survival
17%
Surgical Resection
17%
Radiation Therapy
17%
Bone Metastasis
16%
Hazard Ratio
15%
Sarcoma
14%
Doxorubicin
14%
Metastasis
13%
Ewing Sarcoma
12%
Confidence Interval
12%
Local Recurrence-free Survival
12%
Extraskeletal Osteosarcoma
12%
Resection
11%
Head-and-neck
11%
Ifosfamide
11%
Progression-free Survival
11%
Patient Survival
10%
Disease-specific Survival
10%
Neoadjuvant
10%
Pelvis
10%
Extremity Soft Tissue Sarcoma
9%
Localized Disease
8%
Surgery Therapy
8%
Tumor Size
8%
Phase II Study
8%
Oncologic
8%
Pelvic Metastasis
8%
Osseous Metastasis
8%
Intramedullary Nailing
8%
En Bloc Resection
8%
EWS-FLI1
8%
Postoperative Radiotherapy
8%
Extremity Reconstruction
8%
Clinical Outcomes
8%
High Risk
7%
Prognostic Factors
7%
Trunk
7%
Median Time
6%
Local Therapy
6%
Retrospective Review
6%
Single Institution
6%
Survival Surgery
6%